When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EBS - Emergent Bio launches late-stage study of AV7909
Emergent Biosolutions Inc.
Emergent BioSolutions (NYSE:EBS) initiates a Phase 3 trial enrolling 3,850 subjects to evaluate the lot consistency, immunogenicity, and safety of AV7909 (anthrax vaccine adsorbed with CPG 7909 adjuvant) in healthy adults.
More news on: Emergent BioSolutions Inc., Healthcare stocks news, Stocks on the move,